Xin Huang
Xin Huang joined Eight Roads from BeiGene where he was Business Development Director. Xin focuses on investments in the healthcare sector.

What motivates you?

Investing in truly innovative technology and helping to build world-leading biotech companies in China.

What’s been the steepest learning curve on your career journey so far?

The first six months of my career, when I started at McKinsey New York office after completing my PhD studies at Duke. The transition between the two very different worlds - academia and business - was both challenging and deeply exciting. The structured thinking and hypothesis driven analysis are similar, however the real commercial world setting, the human elements, and the fine balance between perfection and execution-ability were new and critical.

Which global technology trend are you most excited about at the moment and why?

Immuno-oncology therapies, gene editing and artificial intelligence. Although there is still a long way to go, immune-oncology therapy brings cancer patients the hope to survive longer and even be cured. Gene editing and AI will change our therapeutics and healthcare service significantly, and eventually our lives in a fundamental way. 

If you could give a piece of advice to your 20-year-old self, what would it be?

Start a business or multiple businesses, as the experience (no matter whether they end in success or failure) will definitely benefit your whole life.